HLA-DRB1∗03:01 and HLA-DRB1∗04:01 modify the presentation and outcome in autoimmune hepatitis type-1

Genes and Immunity

Volumn 16, Issue 4, 2015, Pages 247-252

  Van Gerven, N M F ^a   De Boer, Y S ^a   Zwiers, A ^a   Verwer, B J ^a   Drenth, J P H ^b   Van Hoek, B ^c   Van Erpecum, K J ^d   Beuers, U ^e   Van Buuren, H R ^f   Den Ouden, J W ^g   Verdonk, R C ^h,i   Koek, G H ^j   Brouwer, J T ^k   Guichelaar, M M J ^l   Vrolijk, J M ^m   Coenraad, M J ^c   Kraal, G ^a   Mulder, C J J ^a   Van Nieuwkerk, C M J ^a   Bloemena, E ^a   Verspaget, H W ^b   Kumar, V ^h   Zhernakova, A ^h   Wijmenga, C ^h   Franke, L ^h   Bouma, G ^a   Baak, L C ⁿ   Baven Pronk, A M ^c   Klempt Kropp, M ^o   Van Meyel, J J M ⁿ   Linskens, R K ^p   Spanier, B W ^m   Kneppelhout, J C ^p   Kuyvenhoven, J Ph ^q   Van Geenen, E J M ^b   Wagtmans, M J ^r   Cahen, D L ^s   Wolfhagen, F H J ^t   Kingma, P J ^u   De Vree, J M L ^h   Loffeld, R J L F ^v   De Man, Rob A ^f   Friederich, P W ^w   Schreuder, T C M A ^x   Van Milligen De Wit, A W M ^y   Alleman, M A ^z   Bhalla, A ^g   Stadhouders, P H G M ⁱ   Verhagen, M A M T ^aa   more..

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g HAGA HOSPITAL   (Netherlands)

^h UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

ⁱ ST ANTONIUS HOSPITAL   (Netherlands)

^j MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^k REINIER DE GRAAF HOSPITAL   (Netherlands)

^l MEDISCH SPECTRUM TWENTE   (Netherlands)

^m RIJNSTATE HOSPITAL   (Netherlands)

ⁿ ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^o Medical Centre Alkmaar   (Netherlands)

^p ST ANNA HOSPITAL   (Netherlands)

^q Department of Orthopaedic Surgery   (Netherlands)

^r RED CROSS HOSPITAL   (Netherlands)

^s AMSTELLAND HOSPITAL   (Netherlands)

^t Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

^u TERGOOI HOSPITAL   (Netherlands)

^v ZAANS MEDICAL CENTER   (Netherlands)

^w MEANDER MEDICAL CENTER   (Netherlands)

^x SLINGELAND HOSPITAL   (Netherlands)

^y AMPHIA HOSPITAL   (Netherlands)

^z Isala   (Netherlands)

^aa DEPARTMENT OF SURGERY   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; GENOMIC DNA; HLA DRB1 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; HLA-DRB1*03:01 ANTIGEN; HLA-DRB1*04:01 ANTIGEN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLELE; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL FEATURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; BLOOD; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETICS; HEPATITIS, AUTOIMMUNE; IMMUNOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; ONSET AGE; TREATMENT OUTCOME;

ADULT; AGE OF ONSET; AGED; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS, AUTOIMMUNE; HLA-DRB1 CHAINS; HUMANS; IMMUNOGLOBULIN G; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; TREATMENT OUTCOME;

EID: 84930477854     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2014.82     Document Type: Article

References (32)

1. Boberg KM. Prevalence and epidemiology of autoimmune hepatitis. Clin Liver Dis 2002; 6: 635-647.
2. Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 51: 2193-2213.
3. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938.
4. Van Gerven NM, Verwer BJ, Witte BI, van Erpecum KJ, van Buuren HR, Maijers I et al. Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands. Scand J Gastroenterol 2014; 49: 1245-1254.
5. Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 2011; 54: 374-385.
6. Woodward J, Neuberger J. Autoimmune overlap syndromes. Hepatology 2001; 33: 994-1002.
7. Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48: 169-176.
8. Czaja AJ, Strettell MD, Thomson LJ, Santrach PJ, Moore SB, Donaldson PT et al. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology 1997; 25: 317-323.
9. Doherty DG, Donaldson PT, Underhill JA, Farrant JM, Duthie A, Mieli-Vergani G et al. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology 1994; 19: 609-615.
10. Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 1991; 13: 701-706.
11. Oliveira LC, Porta G, Marin ML, Bittencourt PL, Kalil J, Goldberg AC. Autoimmune hepatitis, HLA and extended haplotypes. Autoimmun Rev 2011; 10: 189-193.
12. Seki T, Ota M, Furuta S, Fukushima H, Kondo T, Hino K et al. HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology 1992; 103: 1041-1047.
13. van Gerven NM, de Boer YS, Zwiers A, van Hoek B, van Erpecum KJ, Beuers U et al. Cytotoxic T lymphocyte antigen-4 +49A/G polymorphism does not affect susceptibility to autoimmune hepatitis. Liver Int 2013; 33: 1039-1043.
14. Schott E, Witt H, Pascu M, van Boemmel F, Weich V, Bergk A et al. Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease. Eur J Gastroenterol Hepatol 2007; 19: 947-951.
15. Bittencourt PL, Palacios SA, Cancado EL, Porta G, Carrilho FJ, Laudanna AA et al. Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil. Am J Gastroenterol 2003; 98: 1616-1620.
16. Czaja AJ. Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis. Clin Gastroenterol Hepatol 2008; 6: 379-388.
17. de Boer YS, van Gerven NM, Zwiers A, Verwer BJ, van Hoek B, van Erpecum KJ et al. Genome-wide association study identifies variants associated with autoimmune hepatitis type 1. Gastroenterology 2014; 147: 443-452 e5.
18. Fujinami RS, Oldstone MB. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 1985; 230: 1043-1045.
19. Enouz S, Carrie L, Merkler D, Bevan MJ, Zehn D. Autoreactive T cells bypass negative selection and respond to self-antigen stimulation during infection. J Exp Med 2012; 209: 1769-1779.
20. Longhi MS, Ma Y, Mieli-Vergani G, Vergani D. Aetiopathogenesis of autoimmune hepatitis. J Autoimmun 2010; 34: 7-14.
21. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology 1993; 105: 1502-1507.
22. Naeim F, Keesey JC, Herrmann C Jr, Lindstrom J, Zeller E, Walford RL. Association of HLA-B8, DRw3, and anti-acetylcholine receptor antibodies in myasthenia gravis. Tissue Antigens 1978; 12: 381-386.
23. Bossini-Castillo L, de Kovel C, Kallberg H, van 't Slot R, Italiaander A, Coenen M et al. A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides. Ann Rheum Dis (e-pub ahead of print 14 February 2014; doi:10.1136/annrheumdis-2013-204591).
24. van Heemst J, van der Woude D, Huizinga TW, Toes RE. HLA and rheumatoid arthritis: How do they connect? Ann Med 2014; 46: 304-310.
25. Ferucci ED, Choromanski TL, Hurlburt KJ, Livingston S, Plotnik J, Manns MP et al. Autoimmune hepatitis in the Alaska Native population: autoantibody profile and HLA associations. Liver Int 2013; 34: 1241-1249.
26. Ma Y, Okamoto M, Thomas MG, Bogdanos DP, Lopes AR, Portmann B et al. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology 2002; 35: 658-664.
27. Al-Chalabi T, Boccato S, Portmann BC, McFarlane IG, Heneghan MA. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol 2006; 45: 575-583.
28. Czaja AJ, Donaldson PT. Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis. Am J Gastroenterol 2002; 97: 2051-2057.
29. Liu JZ, Almarri MA, Gaffney DJ, Mells GF, Jostins L, Cordell HJ et al. Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. Nat Genet 2012; 44: 1137-1141.
30. Wiencke K, Karlsen TH, Boberg KM, Thorsby E, Schrumpf E, Lie BA et al. Primary sclerosing cholangitis is associated with extende d HLA-DR3 and HLA-DR6 haplotypes. Tissue Antigens 2007; 69: 161-169.
31. Anderson CA, Pettersson FH, Clarke GM, Cardon LR, Morris AP, Zondervan KT. Data quality control in genetic case-control association studies. Nat Protoc 2010; 5: 1564-1573.
32. Jia X, Han B, Onengut-Gumuscu S, Chen WM, Concannon PJ, Rich SS et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS One 2013; 8: e64683.